Overall Survival of Filipino Patients with Squamous Cell Carcinoma of the Head and Neck: A Single-Institution Experience

被引:8
|
作者
Albano, Pia Marie [1 ,2 ,3 ]
Lumang-Salvador, Christianne [6 ]
Orosa, Jose, III [6 ]
Racelis, Sheryl [7 ]
Leano, Modesty [7 ]
Angeles, Lara Mae [3 ,5 ]
Ramos, John Donnie [1 ,3 ,4 ]
机构
[1] Univ Santo Tomas, Res Ctr Nat & Appl Sci, Manila, Philippines
[2] Univ Santo Tomas, Dept Nat Sci, Coll Nursing, Manila, Philippines
[3] Univ Santo Tomas, Grad Sch, Manila, Philippines
[4] Univ Santo Tomas, Coll Sci, Dept Biol Sci, Manila, Philippines
[5] Univ Santo Tomas Hosp, Dept Clin Pathol, Manila, Philippines
[6] Mariano Marcos Mem Hosp & Med Ctr, Dept ENT Head & Neck Surg, Ilocos Norte, Philippines
[7] Mariano Marcos Mem Hosp & Med Ctr, Dept Pathol, Ilocos Norte, Philippines
关键词
Squamous cell carcinoma of the head and neck; survival; treatment; tumor stage; Philippines; HUMAN-PAPILLOMAVIRUS; CANCER INCIDENCE; ORAL-CAVITY; TRENDS; COUNTRIES; MORTALITY;
D O I
10.7314/APJCP.2013.14.8.4769
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This paper is the first to present the incidence and overall survival of patients with squamous cell carcinoma of the head and neck (SCCHN) from the extreme northern part of the Philippines. We retrospectively retrieved the records of patients with histologically-confirmed squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx and larynx at the Mariano Marcos Memorial Hospital and Medical Center, Ilocos Norte, Philippines, from 2003 to 2012 and analysed prognostic factors associated with survival. Of the 150 cases, only 80 (53.3%) were still living when the study was terminated. Median age at initial diagnosis was 61.5 years and the male to female ration was 7:3. The majority of the cases had tumours in the oral cavity (50.7%), followed by the larynx (36.7%). Sex (log rank=1.94, p value/alpha=0.16), tumor site (log rank=0.02, p value/alpha=0.90), tumor grade (log rank=1.74, p value/alpha=0.42). and node state (log rank=0.07, p value/alpha=0.80) were not shown to be associated with the survival of our cases. Only 45 (30.0%) had no regional lymph node involvement (N0) at presentation and 12 (8.0%) had already developed distant metastases. Among the 150 patients, 71 (47.3%) were not able to receive treatment of any kind. Oddly, treatment (log rank=1.65, p value/alpha=0.20) was also shown to be not associated with survival. The survival rate of those who underwent surgery, radiotherapy, of both was not statistically different from those who did not receive any treatment. Only the tumor state (log rank=4.51, p value/alpha=0.03) was associated with patient survival. The overall mean survival was 49.3 months, with survival rate diminishing from 88.3% during the 1st year to 1.80% by end of the study. This relatively low survival rate of our cases only reflects their poor access to quality diagnostic and treatment facilities.
引用
收藏
页码:4769 / 4774
页数:6
相关论文
共 50 条
  • [31] Perioperative Survival of Elderly Head and Neck Squamous Cell Carcinoma Patients
    Stokes, William A.
    Fuller, Collin
    Day, Terry A.
    Gillespie, Marion B.
    LARYNGOSCOPE, 2014, 124 (10): : 2281 - 2286
  • [32] The impact of comorbidity on the survival of patients with squamous cell carcinoma of the head and neck
    Hall, SF
    Groome, PA
    Rothwell, D
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2000, 22 (04): : 317 - 322
  • [33] Radioimmunotherapy in patients with head and neck squamous cell carcinoma: Initial experience
    Colnot, DR
    Quak, JJ
    Roos, JC
    de Bree, R
    Wilhelm, AJ
    Snow, GB
    van Dongen, GAMS
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2001, 23 (07): : 559 - 565
  • [34] Osteosarcoma of the head and neck region: Lessons learned from a single-institution experience of 50 patients
    Laskar, Siddhartha
    Basu, Ayan
    Muckaden, Mary Ann
    D'Cruz, Anil
    Pai, Suresh
    Jambhekar, Nirmala
    Tike, Pramod
    Shrivastava, Shyam K.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2008, 30 (08): : 1020 - 1026
  • [35] End-of-life care pathway of head and neck cancer patients: single-institution experience
    Heinonen, T.
    Loimu, V.
    Saarilahti, K.
    Saarto, T.
    Makitie, A.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2018, 275 (02) : 545 - 551
  • [36] End-of-life care pathway of head and neck cancer patients: single-institution experience
    T. Heinonen
    V. Loimu
    K. Saarilahti
    T. Saarto
    A. Mäkitie
    European Archives of Oto-Rhino-Laryngology, 2018, 275 : 545 - 551
  • [37] Overall Survival and Adjuvant Therapy in Women with Ovarian Carcinosarcoma: A Single-Institution Experience
    Nizam, Aaron
    Bustamante, Bethany
    Shan, Weiwei
    Shih, Karin K.
    Whyte, Jill S.
    Sakaris, Antoinette
    dos Santos, Lisa
    Frimer, Marina
    Menzin, Andrew W.
    Truskinovsky, Alexander
    Goldberg, Gary L.
    DIAGNOSTICS, 2019, 9 (04)
  • [38] Overall Survival for Esophageal Squamous Cell Carcinoma with Multiple Primary Cancers after Curative Esophagectomy-A Retrospective Single-Institution Study
    Tsai, Ping-Chung
    Ting, Ying-Che
    Hsu, Po-Kuei
    Hung, Jung-Jyh
    Huang, Chien-Sheng
    Hsu, Wen-Hu
    Hsu, Han-Shui
    CANCERS, 2022, 14 (21)
  • [39] IS THERE A ROLE FOR INDUCTION CHEMOTHERAPY (ICT) IN LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA (LAHNSCC)? A SINGLE INSTITUTION EXPERIENCE
    Sargento, I.
    Oliveira, M.
    Esteves, S.
    Luis, A. C. H.
    Trindade, C.
    Ferreira, M.
    Oliveira, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 318 - 318
  • [40] Clinicopathologic and survival analysis of patients with adenoid cystic carcinoma of vulva: single-institution experience
    Jun Zhu
    Lina Yin
    Qifeng Wang
    Xiaohua Wu
    Guihao Ke
    International Journal of Clinical Oncology, 2020, 25 : 2144 - 2150